Emergent BioSolutions Inc.
Giá lên
Cập nhật

EBS: Operation Warp Speed Timeline

169
Emergent BioSolutions is well known for owning the rights to the pioneering technology behind the Narcan nasal spray. Naloxone has been around for years as an injectable for opioid overdoses which required expertise to administer. Narcan spray eliminated the expertise requirement.

Recently, EBS entered into several large contracts with giant pharma and will serve as manufacturers of leading COVID-19 vaccine candidates. They are working with Department of Defense; Department of Health and Human Services; Johnson & Johnson; and AstraZeneca.

The deal with JNJ starts in 2021 and lasts 5 years.

As more and more vaccines pass trials and get approved, biotech companies will need a manufacturer to sign with and I believe that EBS will be the go-to because of their size and ability to scale.

Currently waiting for a buy signal.
Ghi chú
ảnh chụp nhanh

Buy signal is in.
Ghi chú
ảnh chụp nhanh

Did some tweaks to the script. The pattern that appears repeat is: the dominant trend will reverse once price enters the colored areas.

Additionally, the holding period for this stock range from 2 weeks to 1 month.

Thông báo miễn trừ trách nhiệm

Thông tin và ấn phẩm không có nghĩa là và không cấu thành, tài chính, đầu tư, kinh doanh, hoặc các loại lời khuyên hoặc khuyến nghị khác được cung cấp hoặc xác nhận bởi TradingView. Đọc thêm trong Điều khoản sử dụng.